Cleared Traditional

K921746 - VITEK IMMUNODIAGNOSTIC ASSAY SYSTEM

K921746 is an FDA 510(k) clearance for VITEK IMMUNODIAGNOSTIC ASSAY SYSTEM, manufactured by Biomerieux Vitek, Inc.. The device is a Class 1 Chemistry device with product code CGJ cleared through the Traditional 510(k) pathway after a 64-day FDA review.

K921746 · Biomerieux Vitek, Inc. · Chemistry device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 1992
Decision
64d
Days
Class 1
Risk

K921746 is an FDA 510(k) clearance for the VITEK IMMUNODIAGNOSTIC ASSAY SYSTEM. Classified as Radioimmunoassay, Follicle-stimulating Hormone (product code CGJ), Class I - General Controls.

Submitted by Biomerieux Vitek, Inc. (Rockland, US). The FDA issued a Cleared decision on June 16, 1992 after a review of 64 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1300 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K921746

510(k) Number K921746 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 13, 1992
Decision Date June 16, 1992
Days to Decision 64 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 89d · This submission: 64d
Pathway characteristics
Predicate-based equivalence.

CGJ Device Classification - Class 1, General Controls

Product Code CGJ Radioimmunoassay, Follicle-stimulating Hormone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1300
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CGJ Radioimmunoassay, Follicle-stimulating Hormone

All 86
Devices cleared under the same product code (CGJ) and FDA review panel - the closest regulatory comparables to K921746.
ACCESS HUMAN FOLLICLE STIMULATING HORMONE ASSAY
K940005 · Bio-Rad Laboratories, Inc. · Mar 1994
COBAS CORE FSH EIA
K930304 · Roche Diagnostic Systems, Inc. · Sep 1993
ICN BIOMEDICALS IMMUCHEM(TM) FSH-MW ELISA KIT
K922376 · Icn Biomedicals, Inc. · Oct 1992
IMMULITE(R) FSH
K921704 · Cirrus Diagnostics, Inc. · Jun 1992
ELISA TUBE FSH TEST KIT ENZYME LINKED IMMUN. ASSAY
K920917 · Bio Clinic Co. · Mar 1992
FSH ENZYME IMMUNASSAY TEST KIT NO:KIF4057
K915208 · Medix Biotech, Inc. · Dec 1991
K921746 · VITEK IMMUNODIAGNOSTIC ASSAY SYSTEM
Download PDF FDA Summary Biomerieux Vitek, Inc.